Theraclone Sciences has named Clifford J. Stocks chief executive officer.
Stocks most recently served as chief business officer of Calistoga Pharmaceuticals. Stocks brings more than two decades of experience in the biotech industry, including 15 years at ICOS where he served as an executive officer and vice president of business development.
"Cliff is known in the biotech industry as a skilled collaboration architect and a strong deal maker, and we have every confidence that he will help us achieve our objectives." said Steven Gillis, Ph.D., managing director at ARCH Venture Partners and executive chairman of Theraclone.